OPCH vs PACS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
OPCH · Option Care Health$31.59 ▼ 0.06%
PACS · PACS Group$43.67 ▲ 1.49%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- OPCH +5.6%
- PACS +45.8%
Head to head
| Metric | OPCH | PACS |
|---|---|---|
| Price | $31.59 | $43.67 |
| Change today | ▼ 0.06% | ▲ 1.49% |
| Market cap | $4.73B | $6.93B |
| Return, 3 months | +33.5% | -1.3% |
| Return, year to date | -0.8% | +13.8% |
| Return, 1 year | +6.8% | +58.8% |
| P/E (TTM) | 22.9 | 24.8 |
| P/B | 3.6 | 5.7 |
| P/E percentile vs own 5y | 34th | 55th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +4.1% | +11.5% |
| Net profit growth (YoY) | +10.8% | +16.2% |
| Gross margin | 19.1% | 17.1% |
| Operating margin | 5.9% | 7.4% |
| Net margin | 3.7% | 4.9% |
| Return on equity | 16.0% | 26.6% |
| Analyst target vs. price | +2.2% | +38.9% |
| Analyst buy share | 29% | 100% |
| RSI (14) | 69 | 39 |
| 30-day volatility | 6.4% | 50.7% |
| Max drawdown, 1 year | -46.7% | -27.9% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PACS is the largest of the group by market value.
- PACS has returned the most over the past year.
- OPCH carries the lowest trailing P/E.
- PACS is growing revenue fastest.
- PACS keeps the most profit per dollar of sales.
- OPCH has been the calmest stock over the last 30 days.